Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.24 USD | -1.72% | -3.42% | -3.26% |
Jan. 21 | Morgan Stanley Adjusts Merck Price Target to $113 From $123, Maintains Equal Weight Rating | MT |
Jan. 17 | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG MSCI | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
A | 243B | ||||||||
A | 668B | ||||||||
A | 357B | ||||||||
AAA | 356B | ||||||||
A | 305B | ||||||||
A | 240B | ||||||||
AA | 211B | ||||||||
AA | 197B | ||||||||
A | 151B | ||||||||
A | 148B | ||||||||
BBB | 129B | ||||||||
AAA | 116B | ||||||||
A | 116B | ||||||||
AA | 69.56B | ||||||||
AA | 68.29B | ||||||||
AAA | 53.8B | ||||||||
A | 41.18B | ||||||||
A | 40.97B | ||||||||
A | 39.47B | ||||||||
Average | AA | 186.79B | |||||||
Weighted average by Cap. | AA |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector ratings